Lenzilumab
Product Specifications
UNSPSC Description
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies[1][2].
Target Antigen
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lenzilumab.html
Purity
99.64
Solubility
10 mM in DMSO
Smiles
[Lenzilumab]
References & Citations
[1]Rosalie M Sterner, et al. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood. 2019 Feb 14;133(7):697-709.|[2]Zelalem Temesgen, et al. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov;95(11):2382-2394.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99207/Lenzilumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99207/Lenzilumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1229575-09-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9943742-01 48 Well
Canine Rho Guanine Nucleotide Exchange Factor 9 (ARHGEF9) ELISA Kit
Ask
View Details 
MBS9943742-02 96 Well
Canine Rho Guanine Nucleotide Exchange Factor 9 (ARHGEF9) ELISA Kit
Ask
View Details 
MBS9943742-03 5x 96 Well
Canine Rho Guanine Nucleotide Exchange Factor 9 (ARHGEF9) ELISA Kit
Ask
View Details MBS9943742-04 10x 96 Well
Canine Rho Guanine Nucleotide Exchange Factor 9 (ARHGEF9) ELISA Kit
Ask
View Details